Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 21 Apr 2022 18:00 CEST |
LAGARDERE SA | Lagardère SA extends the maturity of its financial liquidity | 40301030 Publishing | Legal |
| 21 Apr 2022 18:00 CEST |
MEDESIS PHARMA S.A. | MEDESIS PHARMA - Mise à disposition du Rapport Financier Annuel 2021 | 20103010 Biotechnology | Legal |
| 21 Apr 2022 18:00 CEST |
LAGARDERE SA | Lagardère SA allonge la maturité de sa liquidité financière | 40301030 Publishing | Legal |
| 21 Apr 2022 18:00 CEST |
KERLINK | Kerlink annonce sa participation à l’opération de prévente de l’Initial Coin Offering (ICO) de la société Kalima, spécialiste français de la blockchain industrielle. | 15101010 Telecommunications Equipment | Legal |
| 21 Apr 2022 18:00 CEST |
LATECOERE | Latécoère annonce la réalisation d’une augmentation de capital réservée à certains managers du Groupe pour un montant d’environ 2,4 millions d’euros | 50201010 Aerospace | Other subject |
| 21 Apr 2022 18:00 CEST |
LATECOERE | Latécoère Announces the Completion of a Capital Increase Reserved for Certain Group Managers for an Amount of Approximately €2.4 Million | 50201010 Aerospace | Other subject |
| 21 Apr 2022 18:00 CEST |
GENOMIC VISION | GENOMIC VISION : RÉSULTATS ANNUELS 2021 | 20103010 Biotechnology | Income |
| 21 Apr 2022 18:00 CEST |
GENOMIC VISION | Genomic Vision: 2021 Annual Results | 20103010 Biotechnology | Income |
| 21 Apr 2022 18:00 CEST |
IMMOB.DASSAULT | IMMOBILIERE DASSAULT : Revenus locatifs du 1er trimestre 2022 quasi-stables à 6,3 M€ | 35102000 Diversified REITs | Sales |
| 21 Apr 2022 18:00 CEST |
AMPLITUDE SURGICAL | Amplitude Surgical - Chiffre d’affaires consolidé 9 mois de 77,3 M€ en progression de +4,0% à taux constants | 20102010 Medical Equipment | Sales |
| 21 Apr 2022 18:00 CEST |
AMPLITUDE SURGICAL | Amplitude Surgical – Consolidated 9-Month Sales of €77.3 Million, up 4.0% at Constant Exchange Rates | 20102010 Medical Equipment | Sales |
| 21 Apr 2022 18:00 CEST |
NOXXON PHARMA | NOXXON ANNONCE UN FINANCEMENT DE 2,375 MILLIONS D'EUROS DANS LE CADRE DE L'ACCORD AVEC ATLAS | 20103010 Biotechnology | Other subject |
| 21 Apr 2022 18:00 CEST |
NOXXON PHARMA | NOXXON Announces €2.375 Million Financing Under Agreement With Atlas | 20103010 Biotechnology | Other subject |
| 21 Apr 2022 18:00 CEST |
ACTIA GROUP | ACTIA Group : Information relative au nombre total de droits de vote et d’actions composant le Capital Social | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 21 Apr 2022 18:00 CEST |
KERLINK | Kerlink Announces Participation in Pre-Sale Initial Coin Offering By Kalima, French Industrial Blockchain Specialist | 15101010 Telecommunications Equipment | Legal |
| 21 Apr 2022 18:00 CEST |
I.CERAM | I.CERAM : Brevet délivré aux Etats-Unis sur l\'implant en céramique poreuse chargé en principes actifs | 20102015 Medical Supplies | Legal |
| 21 Apr 2022 18:00 CEST |
ADVICENNE | Advicenne nomme Philippe BOUCHERON Président de son Conseil d’administration | 20103010 Biotechnology | Journal / appointments |
| 21 Apr 2022 18:00 CEST |
ADVICENNE | Advicenne Appoints Philippe Boucheron as Chairman of its Board of Directors | 20103010 Biotechnology | Journal / appointments |
| 21 Apr 2022 18:00 CEST |
SOGECLAIR | Sogeclair: AGM du 12 mai 2022 - Mise à disposition des documents préparatoires | 50101015 Engineering and Contracting Services | General meeting / Board Meeting |
| 21 Apr 2022 18:00 CEST |
SOGECLAIR | Sogeclair: Combined General Meeting of May 12, 2022: availability of preparatory documents | 50101015 Engineering and Contracting Services | General meeting / Board Meeting |
| 21 Apr 2022 18:00 CEST |
L'OREAL | L'Oréal : Communiqué : "Assemblée Générale Mixte et Conseil d’Administration du 21 avril 2022" | 40204035 Cosmetics | General meeting / Board Meeting |
| 21 Apr 2022 18:00 CEST |
L'OREAL | L'Oréal: News Release: "Annual General Meeting and Board of Directors’ Meeting of 21 April 2022" | 40204035 Cosmetics | General meeting / Board Meeting |
| 21 Apr 2022 18:00 CEST |
REXEL | ASSEMBLEE GENERALE DE REXEL DU 21 AVRIL 2022 | 50202010 Electrical Components | General meeting / Board Meeting |
| 21 Apr 2022 18:00 CEST |
REXEL | REXEL ANNUAL SHAREHOLDERS’ MEETING OF APRIL 21st, 2022 | 50202010 Electrical Components | General meeting / Board Meeting |
| 21 Apr 2022 18:00 CEST |
ALBIOMA | ALBIOMA : Information financière trimestrielle au 31 mars 2022 | 65101010 Alternative Electricity | Commercial results |
| 21 Apr 2022 18:00 CEST |
ALBIOMA | Albioma : Financial information for the quarter ended 31 March 2022 | 65101010 Alternative Electricity | Commercial results |
| 21 Apr 2022 18:00 CEST |
ORAPI | ORAPI: Chiffre d'affaires du T1 2022 _ Bonne dynamique | 55201000 Chemicals: Diversified | Sales |
| 21 Apr 2022 17:58 CEST |
CASCF1.875%07JUN23 | CREDIT AGRICOLE PUBLIC SECTOR SCF : Mise à disposition du Rapport Financier Annuel 2021 | - | Other subject |
| 21 Apr 2022 17:55 CEST |
SHOWROOMPRIVE | CHIFFRE D'AFFAIRES DU 1ER TRIMESTRE 2022 | 40401020 Apparel Retailers | Sales, Income, Commercial results |
| 21 Apr 2022 17:55 CEST |
SHOWROOMPRIVE | CHIFFRE D'AFFAIRES DU 1ER TRIMESTRE 2022 | 40401020 Apparel Retailers | Sales, Income, Commercial results |
| 21 Apr 2022 17:55 CEST |
SHOWROOMPRIVE | CHIFFRE D'AFFAIRES DU 1ER TRIMESTRE 2022 | 40401020 Apparel Retailers | Sales, Income, Commercial results |
| 21 Apr 2022 17:53 CEST |
IMMERSION | Communiqué de Presse - Résultats semestriels 2021/2022 | 10101015 Software | Commercial results |
| 21 Apr 2022 17:53 CEST |
MERIDIA RE IV SOCIMI | Closing MGP and distribution of capital contribution | 35102000 Diversified REITs | Mergers, Acquiqitions, Transferts |
| 21 Apr 2022 17:51 CEST |
CLASQUIN | CLASQUIN : Mise à disposition du Rapport Annuel 2021 | 50206040 Delivery Services | Legal |
| 21 Apr 2022 17:50 CEST |
AUBAY | 2022 first-quarter revenue: EUR 129.5 million Strong organic growth: +11.7% | 10101010 Computer Services | Sales, Income |
| 21 Apr 2022 17:50 CEST |
AUBAY | 2022 first-quarter revenue: EUR 129.5 million Strong organic growth: +11.7% | 10101010 Computer Services | Sales, Income |
| 21 Apr 2022 17:50 CEST |
AUBAY | Chiffre d'affaires du premier trimestre 2022 : 129,5 M EUR - Forte croissance interne : +11,7% | 10101010 Computer Services | Sales, Income |
| 21 Apr 2022 17:50 CEST |
AUBAY | Chiffre d'affaires du premier trimestre 2022 : 129,5 M EUR - Forte croissance interne : +11,7% | 10101010 Computer Services | Sales, Income |
| 21 Apr 2022 17:50 CEST |
ALPES (COMPAGNIE) | CDA - H1 2021 2022 sales | 40501030 Recreational Services | General meeting / Board Meeting |
| 21 Apr 2022 17:49 CEST |
Makheia Group | Makheia • Une année de stabilisation et retour à la rentabilité avec un ROC positif | 40301020 Media Agencies | General meeting / Board Meeting |
| 21 Apr 2022 17:48 CEST |
FDJ | FDJ : 1er trimestre 2022 | 40501020 Casinos and Gambling | Other subject |
| 21 Apr 2022 17:48 CEST |
FDJ | FDJ: Q1 2022 | 40501020 Casinos and Gambling | Other subject |
| 21 Apr 2022 17:47 CEST |
IPSOS | Premier trimestre 2022 : une bonne performance | 40301020 Media Agencies | Income |
| 21 Apr 2022 17:47 CEST |
IPSOS | First quarter 2022: Performing well | 40301020 Media Agencies | Income |
| 21 Apr 2022 17:45 CEST |
LINEDATA SERVICES | Linedata Services: Q1 2022 Revenue: €40.1 Million (+5.9%) | 10101015 Software | Sales |
| 21 Apr 2022 17:45 CEST |
LINEDATA SERVICES | Linedata Services: Chiffre d'affaires du 1er trimestre 2022 : 40,1 M€ (+5,9%) | 10101015 Software | Sales |
| 21 Apr 2022 17:45 CEST |
COVIVIO | Covivio - Activity at end-march 2022 : Strong recovery confirmed in the first quarter of 2022 | 35102030 Office REITs | Corporate life |
| 21 Apr 2022 17:45 CEST |
SPARTOO | SPARTOO : INFORMATION MENSUELLE RELATIVE AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL ET AU NOMBRE TOTAL DES DROITS DE VOTE | 40401020 Apparel Retailers | Other subject |
| 21 Apr 2022 17:45 CEST |
BOIRON | Chiffre d'affaires du premier trimestre 2022 | 20103015 Pharmaceuticals | Sales, Income |
| 21 Apr 2022 17:45 CEST |
BOIRON | Chiffre d'affaires du premier trimestre 2022 | 20103015 Pharmaceuticals | Sales, Income |